{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:14:18Z","timestamp":1788189258952,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"DOI":"10.1007\/s43441-026-01040-9","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:19:08Z","timestamp":1788185948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of Authorized Clinical Trials in Peru, 2017\u20132025: A National Registry-Based Study"],"prefix":"10.1007","author":[{"given":"Liz","family":"Mendoza-Aucaruri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Gabriel","family":"Acevedo-Cahuana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritzi Pilar","family":"Villalba-Ugarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ttito-Paricahua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Andr\u00e9","family":"Ale-Mauricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Taype-Rondan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"1040_CR1","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMms1604593","volume":"374","author":"LE Bothwell","year":"2016","unstructured":"Bothwell LE, Greene JA, Podolsky SH, et al. Assessing the gold standard\u2014lessons from the history of RCTs. N Engl J Med. 2016;374:2175\u201381. https:\/\/doi.org\/10.1056\/NEJMms1604593.","journal-title":"N Engl J Med"},{"key":"1040_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13643-024-02728-5","volume":"13","author":"A Hohlfeld","year":"2024","unstructured":"Hohlfeld A, Kredo T, Clarke M. A scoping review of activities intended to reduce publication bias in randomised trials. Syst Rev. 2024;13:310. https:\/\/doi.org\/10.1186\/s13643-024-02728-5.","journal-title":"Syst Rev"},{"key":"1040_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26633\/RPSP.2017.31","volume":"41","author":"P Rodr\u00edguez-Feria","year":"2017","unstructured":"Rodr\u00edguez-Feria P, Cuervo LG. Progress in trial registration in Latin America and the Caribbean, 2007\u20132013. Rev Panam Salud Publica. 2017;41:1. https:\/\/doi.org\/10.26633\/RPSP.2017.31.","journal-title":"Rev Panam Salud Publica"},{"key":"1040_CR4","unstructured":"Ministerio de Salud del Per\u00fa. Resoluci\u00f3n Ministerial 089-2003-SA\/DM. Disponen que el procedimiento administrativo establecido en el TUPA del Ministerio sea de competencia del Instituto Nacional de Salud [Internet]. Lima: MINSA; 2003. https:\/\/www.gob.pe\/institucion\/minsa\/normas-legales\/254370-089-2003-sa-dm."},{"key":"1040_CR5","unstructured":"Ministerio de Salud del Per\u00fa. Decreto Supremo 017-2006-SA. Aprueban el Reglamento de Ensayos Cl\u00ednicos en el Per\u00fa [Internet]. Lima: MINSA; 2006. https:\/\/www.gob.pe\/institucion\/minsa\/normas-legales\/251170-017-2006-sa."},{"key":"1040_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/jebm.12354","volume":"12","author":"CA Alarcon\u2010Ruiz","year":"2019","unstructured":"Alarcon\u2010Ruiz CA, Roque\u2010Roque JS, Heredia P, et al. Twenty\u2010two years\u2019 experience registering trials in a low\u2010middle income country: the Peruvian Clinical Trial Registry. J Evid Based Med. 2019;12:187\u201393. https:\/\/doi.org\/10.1111\/jebm.12354.","journal-title":"J Evid Based Med"},{"key":"1040_CR7","unstructured":"Registro Peruano de Ensayos Cl\u00ednicos (REPEC). Introduction [Internet]. Lima: Instituto Nacional de Salud del Per\u00fa; [cited 2026 May 10]. https:\/\/ensayosclinicos-repec.ins.gob.pe\/en\/about-repec\/introduction. Accessed 10 May 2026."},{"key":"1040_CR8","unstructured":"World Health Organization. New member of the registry: Peruvian Clinical Trials Registry (REPEC) [Internet]. Geneva: WHO; 2016 [cited 2026 May 13]. https:\/\/www.who.int\/news\/item\/22-07-2016-repec. Accessed 13 May 2026."},{"key":"1040_CR9","unstructured":"Ministerio de Salud del Per\u00fa. Resoluci\u00f3n Ministerial 021-2017\/MINSA. Modificaci\u00f3n del Reglamento de Ensayos Cl\u00ednicos en el Per\u00fa [Internet]. Lima: MINSA; 2017. https:\/\/www.gob.pe\/institucion\/minsa\/normas-legales\/189280-021-2017-sa."},{"key":"1040_CR10","doi-asserted-by":"crossref","unstructured":"Minaya G, Fuentes D, Obreg\u00f3n C, et al. Caracter\u00edsticas de los ensayos cl\u00ednicos autorizados en el Per\u00fa, 1995\u20132012. Revista Peruana de Medicina Experimental y Salud P\u00fablica. Instituto Nacional de Salud; 2012;29:431\u20136.","DOI":"10.1590\/S1726-46342012000400003"},{"key":"1040_CR11","first-page":"1","volume":"18","author":"J Roque-Henriquez","year":"2014","unstructured":"Roque-Henriquez J, Minaya-Mart\u00ednez G, Salinas-Castro E, et al. Situaci\u00f3n de los ensayos cl\u00ednicos y entidades que participan en su ejecuci\u00f3n en el Per\u00fa. Revista Peruana de Epidemiolog\u00eda Sociedad Peruana de Epidemiolog\u00eda. 2014;18:1\u20134.","journal-title":"Revista Peruana de Epidemiolog\u00eda. Sociedad Peruana de Epidemiolog\u00eda"},{"key":"1040_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/jebm.12413","volume":"13","author":"P Heredia","year":"2020","unstructured":"Heredia P, Alarcon\u2010Ruiz CA, Roque\u2010Roque JS, et al. Publication and associated factors of clinical trials registered in Peru. J Evid Based Med. 2020;13:284\u201391. https:\/\/doi.org\/10.1111\/jebm.12413.","journal-title":"J Evid Based Med"},{"key":"1040_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1590\/S1726-46342012000400017","volume":"29","author":"G M\u00e1laga","year":"2012","unstructured":"M\u00e1laga G, Z\u00fa\u00f1iga-Rivera A. \u00bfContribuyen los ensayos cl\u00ednicos al desarrollo de la investigaci\u00f3n en el Per\u00fa?: \u00bfc\u00f3mo lograrlo? Rev Peru Med Exp Salud Publica. 2012;29:529\u201334.","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"1040_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12910-021-00715-2","volume":"22","author":"A Palmero","year":"2021","unstructured":"Palmero A, Carracedo S, Cabrera N, et al. Governance frameworks for COVID-19 research ethics review and oversight in Latin America: an exploratory study. BMC Med Ethics. 2021;22:147. https:\/\/doi.org\/10.1186\/s12910-021-00715-2.","journal-title":"BMC Med Ethics"},{"key":"1040_CR15","unstructured":"Instituto Nacional de Salud de Per\u00fa. Resoluci\u00f3n Jefatural N\u00b0096-2020-J-OPE\/INS. CONFORMAR el Comit\u00e9 Nacional Transitorio de \u00c9tica en Investigaci\u00f3n para la evaluaci\u00f3n y supervisi\u00f3n \u00c9tica de los Ensayos Cl\u00ednicos de la enfermedad COVID-19 [Internet]. Lima: INS; 2020. https:\/\/www.gob.pe\/institucion\/ins\/normas-legales\/862272-096-2020-j-ope-ins."},{"key":"1040_CR16","unstructured":"Instituto Nacional de Salud de Per\u00fa. Resoluci\u00f3n Jefatural N\u00b0097-2020-J-OPE\/INS. APROBAR EL documento del Sistema de Gesti\u00f3n denominado Procedimiento para la revisi\u00f3n \u00e9tica de Ensayos Cl\u00ednicos de la Enfermedad COVID-19\" en el marco de la emergencia sanitaria nacional declarada y que como anexo forma parte de la presente Resoluci\u00f3n. [Internet]. Lima: INS; 2020. https:\/\/www.gob.pe\/institucion\/ins\/normas-legales\/862273-097-2020-j-ope-ins."},{"key":"1040_CR17","unstructured":"Instituto Nacional de Salud de Per\u00fa. Resoluci\u00f3n Jefatural N\u00b0098-2020-J-OPE\/INS. APROBAR EL documento del Sistema de Gesti\u00f3n denominado Procedimiento para la revisi\u00f3n \u00e9tica de Ensayos Cl\u00ednicos de la Enfermedad COVID-19\" en el marco de la emergencia sanitaria nacional declarada y que como anexo forma parte de la presente Resoluci\u00f3n. [Internet]. Lima: INS; 2020. https:\/\/www.gob.pe\/institucion\/ins\/normas-legales\/862274-098-2020-j-ope-ins."},{"key":"1040_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.17843\/rpmesp.2021.381.6627","volume":"38","author":"P Cahuina Lope","year":"2021","unstructured":"Cahuina Lope P, Carracedo S, Romani F. La regulaci\u00f3n de los ensayos cl\u00ednicos para la COVID-19 en el Per\u00fa. Rev Peru Med Exp Salud Publica. 2021;38:171\u20137. https:\/\/doi.org\/10.17843\/rpmesp.2021.381.6627.","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"1040_CR19","unstructured":"Instituto Nacional de Salud de Per\u00fa. Portal de Transparencia Est\u00e1ndar - Instituto Nacional de Salud. [Internet]. Lima: INS; [cited 2026 May 13]. https:\/\/transparencia.gob.pe\/reportes_directos\/pep_transparencia_acceso_informacion.aspx?id_entidad=10032&id_tema=49&cod_rueep=0&ver. Accessed 13 May 2026."},{"key":"1040_CR20","unstructured":"World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic [Internet]. 2023 [cited 2026 May 13]. https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed 13 May 2026."},{"key":"1040_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14072519","volume":"14","author":"G Joshi","year":"2025","unstructured":"Joshi G, Bhandari TK, Joshi P, et al. The current landscape of clinical trials. J Clin Med. 2025;14:2519. https:\/\/doi.org\/10.3390\/jcm14072519.","journal-title":"J Clin Med"},{"key":"1040_CR22","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Coordena\u00e7\u00e3o de Pesquisa Cl\u00ednica em Medicamentos e Produtos Biol\u00f3gicos (COPEC). Relat\u00f3rio de Atividades 2024. [Internet]. Bras\u00edlia: ANVISA; 2024. https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/medicamentos\/pesquisaclinica\/publicacoes\/relatorios-anuais\/2024-copec-_relatorio-de-atividades-2024.pdf."},{"key":"1040_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4067\/S0034-98872021000100110","volume":"149","author":"B Aguilera","year":"2021","unstructured":"Aguilera B. Trends in clinical trials performed in Chile. Rev Med Chile. 2021;149:110\u20138. https:\/\/doi.org\/10.4067\/S0034-98872021000100110.","journal-title":"Rev Med Chile"},{"key":"1040_CR24","first-page":"929","volume":"84","author":"GH Marin","year":"2024","unstructured":"Marin GH, Boni S, Garay V, et al. \u00bfQu\u00e9 se investiga y qui\u00e9n realiza en Argentina la investigaci\u00f3n cl\u00ednica relacionada a medicamentos? Medicina (Buenos Aires). Fundaci\u00f3n Revista Medicina (Buenos Aires). 2024;84:929\u201336.","journal-title":"Fundaci\u00f3n Revista Medicina (Buenos Aires)"},{"key":"1040_CR25","doi-asserted-by":"publisher","first-page":"e0145122","DOI":"10.1371\/journal.pone.0145122","volume":"10","author":"I Atal","year":"2015","unstructured":"Atal I, Trinquart L, Porcher R, et al. Differential globalization of industry- and non-industry\u2013sponsored clinical trials. PLoS ONE. 2015;10:e0145122. https:\/\/doi.org\/10.1371\/journal.pone.0145122.","journal-title":"PLoS ONE"},{"key":"1040_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1590\/S1726-46342010000300012","volume":"27","author":"M Yagui","year":"2010","unstructured":"Yagui M, Espinoza M, Caballero P, et al. Avances y retos en la construcci\u00f3n del sistema nacional de investigaci\u00f3n en salud en el Per\u00fa. Rev Peru Med Exp Salud Publica. 2010;27:387\u201397. https:\/\/doi.org\/10.1590\/S1726-46342010000300012.","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"1040_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12961-020-00581-1","volume":"18","author":"SR Hanney","year":"2020","unstructured":"Hanney SR, Kanya L, Pokhrel S, et al. How to strengthen a health research system: WHO\u2019s review, whose literature and who is providing leadership? Health Res Policy Syst. 2020;18:72. https:\/\/doi.org\/10.1186\/s12961-020-00581-1.","journal-title":"Health Res Policy Syst"},{"key":"1040_CR28","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3390\/healthcare11121753","volume":"11","author":"W De Oliveira Avellar","year":"2023","unstructured":"De Oliveira Avellar W, Ferreira \u00c9A, Vieira ACRA, et al. Clinical cancer research in South America and potential health economic impacts. Healthcare (Basel). 2023;11:1753. https:\/\/doi.org\/10.3390\/healthcare11121753.","journal-title":"Healthcare (Basel)"},{"key":"1040_CR29","doi-asserted-by":"publisher","first-page":"e0192413","DOI":"10.1371\/journal.pone.0192413","volume":"13","author":"PK Drain","year":"2018","unstructured":"Drain PK, Parker RA, Robine M, et al. Global migration of clinical research during the era of trial registration. PLoS ONE. 2018;13:e0192413. https:\/\/doi.org\/10.1371\/journal.pone.0192413.","journal-title":"PLoS ONE"},{"key":"1040_CR30","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.12688\/f1000research.26707.2","volume":"9","author":"P Janiaud","year":"2020","unstructured":"Janiaud P, Axfors C, Van\u2019T Hooft J, et al. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Res. 2020;9:1193. https:\/\/doi.org\/10.12688\/f1000research.26707.2.","journal-title":"F1000Res"},{"key":"1040_CR31","doi-asserted-by":"publisher","first-page":"104086","DOI":"10.1016\/j.esmoop.2024.104086","volume":"10","author":"F Izarn","year":"2025","unstructured":"Izarn F, Henry J, Besle S, et al. Globalization of clinical trials in oncology: a worldwide quantitative analysis. ESMO Open. 2025;10:104086. https:\/\/doi.org\/10.1016\/j.esmoop.2024.104086.","journal-title":"ESMO Open"},{"key":"1040_CR32","unstructured":"Ministerio de Salud del Per\u00fa. Informe de evaluaci\u00f3n de resultados del Plan Estrat\u00e9gico Sectorial Multianual (PESEM) 2016-2025 ampliado del sector salud, correspondiente al a\u00f1o 2022. [Internet]. Lima: MINSA; 2023. https:\/\/www.gob.pe\/institucion\/minsa\/informes-publicaciones\/4587460-informe-de-evaluacion-de-resultados-del-plan-estrategico-sectorial-multianual-pesem-2016-2025-ampliado-del-sector-salud-correspondiente-al-ano-2022."},{"key":"1040_CR33","unstructured":"Ministerio de Salud del Per\u00fa. Centro Nacional de Epidemiolog\u00eda, Prevenci\u00f3n y Control de Enfermedades. Carga de enfermedad en el Per\u00fa: Estimaci\u00f3n de los a\u00f1os de vida saludables perdidos, 2019 [Internet]. Lima: MINSA; 2023. https:\/\/www.dge.gob.pe\/portalnuevo\/wp-content\/uploads\/2024\/05\/CargaEnfermedad2019.pdf."},{"key":"1040_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jclinepi.2018.01.006","volume":"98","author":"I Atal","year":"2018","unstructured":"Atal I, Trinquart L, Ravaud P, et al. A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non\u2013high-income regions. J Clin Epidemiol. 2018;98:123\u201332. https:\/\/doi.org\/10.1016\/j.jclinepi.2018.01.006.","journal-title":"J Clin Epidemiol"},{"key":"1040_CR35","doi-asserted-by":"publisher","first-page":"e1648","DOI":"10.1016\/S2214-109X(25)00218-9","volume":"13","author":"ES Higgs","year":"2025","unstructured":"Higgs ES, Altaf A, Lurie N, et al. National research ecosystems: protecting populations and building health security worldwide. Lancet Glob Health. 2025;13:e1648\u201353. https:\/\/doi.org\/10.1016\/S2214-109X(25)00218-9.","journal-title":"Lancet Glob Health"},{"key":"1040_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1017\/S1745855207005030","volume":"2","author":"A Petryna","year":"2007","unstructured":"Petryna A. Clinical trials offshored: on private sector science and public health. BioSocieties. 2007;2:21\u201340. https:\/\/doi.org\/10.1017\/S1745855207005030.","journal-title":"BioSocieties"},{"key":"1040_CR37","doi-asserted-by":"publisher","first-page":"e017246","DOI":"10.1136\/bmjopen-2017-017246","volume":"7","author":"SRP Franzen","year":"2017","unstructured":"Franzen SRP, Chandler C, Siribaddana S, et al. Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka. BMJ Open. 2017;7:e017246. https:\/\/doi.org\/10.1136\/bmjopen-2017-017246.","journal-title":"BMJ Open"},{"key":"1040_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s43441-025-00742-w","volume":"59","author":"MM Birck","year":"2025","unstructured":"Birck MM, Rasmussen JS, Helmark IC, et al. A sponsor\u2019s best practice and operating principles to manage data monitoring committees. Ther Innov Regul Sci. 2025;59:215\u201321. https:\/\/doi.org\/10.1007\/s43441-025-00742-w.","journal-title":"Ther Innov Regul Sci"},{"key":"1040_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12939-018-0748-6","volume":"17","author":"C Alemayehu","year":"2018","unstructured":"Alemayehu C, Mitchell G, Nikles J. Barriers for conducting clinical trials in developing countries- a systematic review. Int J Equity Health. 2018;17:37. https:\/\/doi.org\/10.1186\/s12939-018-0748-6.","journal-title":"Int J Equity Health"},{"key":"1040_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/1740774520945601","volume":"17","author":"D Wendler","year":"2020","unstructured":"Wendler D. When and how to include vulnerable subjects in clinical trials. Clin Trials. 2020;17:696\u2013702. https:\/\/doi.org\/10.1177\/1740774520945601.","journal-title":"Clin Trials"},{"key":"1040_CR41","doi-asserted-by":"publisher","first-page":"1179268","DOI":"10.3389\/fpubh.2024.1179268","volume":"12","author":"SAC Clemens","year":"2024","unstructured":"Clemens SAC, Gonzalez I, Sereni D, et al. Clinical trial capacity building in a pandemic\u2014outcome of a rapid site readiness project in Latin America. Front Public Health. 2024;12:1179268. https:\/\/doi.org\/10.3389\/fpubh.2024.1179268.","journal-title":"Front Public Health"},{"key":"1040_CR42","doi-asserted-by":"publisher","first-page":"e2518503","DOI":"10.1001\/jamanetworkopen.2025.18503","volume":"8","author":"D Van Hout","year":"2025","unstructured":"Van Hout D, Mouncey P, Harrison D, et al. Hurdles for the delivery of multinational randomized clinical trials. JAMA Netw Open. 2025;8:e2518503. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.18503.","journal-title":"JAMA Netw Open"},{"key":"1040_CR43","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1158\/2159-8290.CD-24-1288","volume":"14","author":"T Adewole","year":"2024","unstructured":"Bloomberg New Economy International Cancer Coalition, Adewole T, Albrecht B, et al. Advancing global health equity in oncology clinical trial access. Cancer Discov. 2024;14:2317\u201323. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-1288.","journal-title":"Cancer Discov"},{"key":"1040_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.17843\/rpmesp.2021.382.8694","volume":"38","author":"P Mayta-Trist\u00e1n","year":"2021","unstructured":"Mayta-Trist\u00e1n P, Aparco JP. El uso de un producto en investigaci\u00f3n fuera de un ensayo cl\u00ednico: el caso \u00abVacunagate\u00bb. Rev Peru Med Exp Salud Publica. 2021;38:203\u20135. https:\/\/doi.org\/10.17843\/rpmesp.2021.382.8694.","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"1040_CR45","doi-asserted-by":"publisher","first-page":"e23038","DOI":"10.1200\/JCO.2024.42.16_suppl.e23038","volume":"42","author":"PRS Nunes Filho","year":"2024","unstructured":"Nunes Filho PRS, Brandalise P, Kannan GS, et al. Latin America and cancer clinical trials: underrepresented region with significant growth potential. J Clin Oncol. 2024;42:e23038\u2013e23038. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.e23038.","journal-title":"J Clin Oncol"},{"key":"1040_CR46","doi-asserted-by":"publisher","first-page":"e013727","DOI":"10.1136\/bmjgh-2023-013727","volume":"9","author":"M Saleh","year":"2024","unstructured":"Saleh M, Sharma K, Shamshudin A, et al. Regulatory approval of clinical trials: Is it time to reinvent the wheel? BMJ Glob Health. 2024;9:e013727. https:\/\/doi.org\/10.1136\/bmjgh-2023-013727.","journal-title":"BMJ Glob Health"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01040-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:19:15Z","timestamp":1788185955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-01040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":46,"alternative-id":["1040"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01040-9","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DAAM and LMA work in the Clinical Trials Evaluation Unit of the Subdirectorate of Clinical Trials at the National Institute of Health (Ministry of Health, Peru).","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}